164 related articles for article (PubMed ID: 33099475)
1. The Association Between the Genetic
Beyene DA; Daremipouran MR; Apprey V; Naab T; Kassim OO; Copeland RL; Kanaan YM
Cancer Genomics Proteomics; 2020; 17(6):739-745. PubMed ID: 33099475
[TBL] [Abstract][Full Text] [Related]
2. The Association of a Novel Identified
Daremipouran MR; Beyene D; Apprey V; Naab TJ; Kassim OO; Copeland RL; Kanaan YM
Cancer Genomics Proteomics; 2019; 16(4):245-255. PubMed ID: 31243105
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor genetic polymorphisms are associated with PSA level, Gleason score and prostate cancer risk in African-American men.
Jingwi EY; Abbas M; Ricks-Santi L; Winchester D; Beyene D; Day A; Naab TJ; Kassim OO; Dunston GM; Copeland RL; Kanaan YM
Anticancer Res; 2015 Mar; 35(3):1549-58. PubMed ID: 25750310
[TBL] [Abstract][Full Text] [Related]
4. Kallikrein 3 and vitamin D receptor polymorphisms: potentials environmental risk factors for prostate cancer.
Hu J; Qiu Z; Zhang L; Cui F
Diagn Pathol; 2014 Apr; 9():84. PubMed ID: 24755043
[TBL] [Abstract][Full Text] [Related]
5. Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population.
Oh JJ; Byun SS; Lee SE; Hong SK; Jeong CW; Kim D; Kim HJ; Myung SC
Gene; 2014 Jan; 533(1):86-93. PubMed ID: 24120391
[TBL] [Abstract][Full Text] [Related]
6. Associations between G/A1229, A/G3944, T/C30875, C/T48200 and C/T65013 genotypes and haplotypes in the vitamin D receptor gene, ultraviolet radiation and susceptibility to prostate cancer.
Moon S; Holley S; Bodiwala D; Luscombe CJ; French ME; Liu S; Saxby MF; Jones PW; Fryer AA; Strange RC
Ann Hum Genet; 2006 Mar; 70(Pt 2):226-36. PubMed ID: 16626332
[TBL] [Abstract][Full Text] [Related]
7. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between vitamin D receptor gene FokI and BsmI polymorphisms and prostate cancer risk: an updated meta-analysis involving 21,756 subjects.
Guo Z; Wen J; Kan Q; Huang S; Liu X; Sun N; Li Z
Tumour Biol; 2013 Oct; 34(5):3189-200. PubMed ID: 23807674
[TBL] [Abstract][Full Text] [Related]
9. Sequence variation within the 5' regulatory regions of the vitamin D binding protein and receptor genes and prostate cancer risk.
Kidd LC; Paltoo DN; Wang S; Chen W; Akereyeni F; Isaacs W; Ahaghotu C; Kittles R
Prostate; 2005 Aug; 64(3):272-82. PubMed ID: 15717311
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.
Holick CN; Stanford JL; Kwon EM; Ostrander EA; Nejentsev S; Peters U
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1990-9. PubMed ID: 17932346
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of low calcium intake and low calcium absorption vitamin D receptor genotype in the California Collaborative Prostate Cancer Study.
Rowland GW; Schwartz GG; John EM; Ingles SA
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):16-24. PubMed ID: 23129590
[TBL] [Abstract][Full Text] [Related]
12. Association of vitamin D receptor gene polymorphisms with prostate cancer risk in the Pakistani population.
Yousaf N; Afzal S; Hayat T; Shah J; Ahmad N; Abbasi R; Ramzan K; Jan R; Khan I; Ahmed J; Siraj S
Asian Pac J Cancer Prev; 2014; 15(22):10009-13. PubMed ID: 25520061
[TBL] [Abstract][Full Text] [Related]
13. Association of SNP-SNP Interactions Between RANKL, OPG, CHI3L1, and VDR Genes With Breast Cancer Risk in Egyptian Women.
Shaker OG; Senousy MA
Clin Breast Cancer; 2019 Feb; 19(1):e220-e238. PubMed ID: 30309792
[TBL] [Abstract][Full Text] [Related]
14. The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population.
Medeiros R; Morais A; Vasconcelos A; Costa S; Pinto D; Oliveira J; Lopes C
J Hum Genet; 2002; 47(8):413-8. PubMed ID: 12181642
[TBL] [Abstract][Full Text] [Related]
15. Use of tanning potential as a predictor for prostate cancer risk in African-American men.
Beyene D; Daremipouran M; Apprey V; Williams R; Ricks-Santi L; Kassim OO; Naab TJ; Kanaan YM; Copeland RL
In Vivo; 2014; 28(6):1181-7. PubMed ID: 25398820
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of vitamin D receptor and the risk of prostate cancer: a meta-analysis.
Zhang Q; Shan Y
J BUON; 2013; 18(4):961-9. PubMed ID: 24344024
[TBL] [Abstract][Full Text] [Related]
17. Association between polymorphisms of the androgen and vitamin D receptor genes with prostate cancer risk in a Mexican population.
Patiño-García B; Arroyo C; Rangel-Villalobos H; Soto-Vega E; Velarde-Félix JS; Gabilondo F; Sandoval-Ramirez L; Figuera LE
Rev Invest Clin; 2007; 59(1):25-31. PubMed ID: 17569297
[TBL] [Abstract][Full Text] [Related]
18. Association of vitamin D receptor polymorphisms with the risk of prostate cancer in the Han population of Southern China.
Bai Y; Yu Y; Yu B; Ge J; Ji J; Lu H; Wei J; Weng Z; Tao Z; Lu J
BMC Med Genet; 2009 Dec; 10():125. PubMed ID: 19961572
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D3 receptor ( VDR ) gene rs2228570 (Fok1) and rs731236 (Taq1) variants are not associated with the risk for multiple sclerosis: results of a new study and a meta-analysis.
García-Martín E; Agúndez JA; Martínez C; Benito-León J; Millán-Pascual J; Calleja P; Díaz-Sánchez M; Pisa D; Turpín-Fenoll L; Alonso-Navarro H; Ayuso-Peralta L; Torrecillas D; Plaza-Nieto JF; Jiménez-Jiménez FJ
PLoS One; 2013; 8(6):e65487. PubMed ID: 23840333
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer risk: associations with ultraviolet radiation, tyrosinase and melanocortin-1 receptor genotypes.
Luscombe CJ; French ME; Liu S; Saxby MF; Jones PW; Fryer AA; Strange RC
Br J Cancer; 2001 Nov; 85(10):1504-9. PubMed ID: 11720436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
